Department of Health and Social Care written question – answered at on 30 January 2018.
To ask the Secretary of State for Health and Social Care, what plans he has to reform the way in which medicines are (a) appraised and (b) funded to ensure that patients have timely access to life-extending medicines at a price that is affordable for the NHS and taxpayer.
On 3 November, the Government published its response to the Accelerated Access Review. It set out plans to give patients quicker access to life-changing treatments; and, make the United Kingdom the best place in the world for industry to invest and innovate. From April 2018, the new Accelerated Access Pathway will mean selected products with the greatest potential to change lives could be available up to four years earlier by reducing the time taken to negotiate the evaluation and financial approvals necessary before the National Health Service can purchase them.
Following a public consultation, NHS England and the National Institute for Health and Care Excellence introduced new arrangements for the appraisal and funding of cancer drugs in July 2016. The new arrangements, including the Cancer Drugs Fund, are designed to ensure that patients benefit from faster access to the most promising new drugs while delivering better value for money for the taxpayer.
Yes0 people think so
No1 person thinks not
Would you like to ask a question like this yourself? Use our Freedom of Information site.